maritide glp 1 What to know about MariTide, Amgen's experimental GLP-1 drug Dual and Triple Gut Peptide

Type 2 Diabetes : A metabolic condition characterized by high blood sugar (hyperglycemia) due to insulin resistance or insufficient insulin production

[23] have shown decreased gene expression of 26 nuclearencoded subunits of the oxidative phosphorylation chain in nondemyelinated motor cortex from MS patients, which coincided with a significant reduction in activity of NADH dehydrogenase and ubiquinolcytochrome c reductase

Autoimmun Rev 15(7):726735

[DOI] [PubMed] [Google Scholar] Liu L, Wu Y, Wang B, Jiang Y, Lin L, Li X, Yang S (2021) DA-DRD5 signaling controls colitis by regulating colonic M1/M2 macrophage polarization